Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Crinobulin: Phase Ia data

Data from a Phase Ia trial in 11 patients showed that 13-30 mg/m

Read the full 135 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE